Literature DB >> 33300264

Hepsin: a multifunctional transmembrane serine protease in pathobiology.

Shuo Li1, Lina Wang2, Shijin Sun2, Qingyu Wu1,2.   

Abstract

Cell membrane-bound serine proteases are important in the maintenance of physiological homeostasis. Hepsin is a type II transmembrane serine protease highly expressed in the liver. Recent studies indicate that hepsin activates prohepatocyte growth factor in the liver to enhance Met signaling, thereby regulating glucose, lipid, and protein metabolism. In addition, hepsin functions in nonhepatic tissues, including the adipose tissue, kidney, and inner ear, to regulate adipocyte differentiation, urinary protein processing, and auditory function, respectively. In mouse models, hepsin deficiency lowers blood glucose, lipid, and protein levels, impairs uromodulin assembly in renal epithelial cells, and causes hearing loss. Elevated hepsin expression has also been found in many cancers. As a type II transmembrane protease, cell surface expression and zymogen activation are essential for hepsin activity. In this review, we discuss the current knowledge regarding hepsin biosynthesis, activation, and functions in pathobiology.
© 2020 Federation of European Biochemical Societies.

Entities:  

Keywords:  adipocyte; cancer; hepatocyte growth factor; hepsin; liver metabolism; normal hearing; type II transmembrane serine proteases; uromodulin

Year:  2020        PMID: 33300264     DOI: 10.1111/febs.15663

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  3 in total

1.  Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients.

Authors:  David Zaragoza-Huesca; Andrés Nieto-Olivares; Francisco García-Molina; Guillermo Ricote; Sofía Montenegro; Manuel Sánchez-Cánovas; Pedro Garrido-Rodríguez; Julia Peñas-Martínez; Vicente Vicente; Francisco Martínez; María Luisa Lozano; Alberto Carmona-Bayonas; Irene Martínez-Martínez
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

2.  The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics.

Authors:  Yan Fang; Hongming Yang; Guiming Hu; Jiakun Lu; Jun Zhou; Na Gao; Yuhan Gu; Cunzhen Zhang; Jinhuan Qiu; Yuanyuan Guo; Yunfei Zhang; Qiang Wen; Hailing Qiao
Journal:  J Transl Med       Date:  2022-02-14       Impact factor: 5.531

Review 3.  Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer.

Authors:  Lucy Lu; Adam Cole; Dan Huang; Qiang Wang; Zhongming Guo; Wancai Yang; Jim Lu
Journal:  Biomolecules       Date:  2022-01-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.